Get started
Author

Neeraja K. Erraguntla

Observed names: Erraguntla, Neeraja, N. Erraguntla, N.K. Erraguntla, Neeraja Erraguntla
ORCID: 0000-0001-6036-8366
Observed ORCID: 0000-0001-6036-8366
OpenAlex ID: A5089120993
Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study
2016 · Nancy B. Beck, Richard A. Becker, et al. · Environment International · 52
PDF
Development of an inhalation unit risk factor for hexavalent chromium
2013 · Joseph T. Haney, Neeraja Erraguntla, et al. · Regulatory Toxicology and Pharmacology · 35
PDF
Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program
2020 · Julie E. Goodman, David B. Mayfield, et al. · Regulatory Toxicology and Pharmacology · 28
PDF
Facilitation of risk assessment with evidence-based methods – A framework for use of systematic mapping and systematic reviews in determining hazard, developing toxicity values, and characterizing uncertainty
2020 · Daniele Wikoff, R. Jeffrey Lewis, et al. · Regulatory Toxicology and Pharmacology · 27
PDF
An updated inhalation unit risk factor for arsenic and inorganic arsenic compounds based on a combined analysis of epidemiology studies
2012 · Neeraja K. Erraguntla, Robert L. Sielken, et al. · Regulatory Toxicology and Pharmacology · 24
Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment
2012 · Joseph T. Haney, Neeraja Erraguntla, et al. · Regulatory Toxicology and Pharmacology · 21
An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene
2022 · C. Valdez-Flores, N. Erraguntla, et al. · Chemico-Biological Interactions · 16
Evaluation of acute inhalation toxicity for chemicals with limited toxicity information
2007 · Roberta L. Grant, Bernard J. Kadlubar, et al. · Regulatory Toxicology and Pharmacology · 14
Improving risk assessment approaches for chemicals with both endogenous and exogenous exposures
2019 · William H. Farland, Angela Lynch, et al. · Regulatory Toxicology and Pharmacology · 11
PDF
Derivation of a no‐significant‐risk‐level for tetrabromobisphenol A based on a threshold non‐mutagenic cancer mode of action
2018 · Alison M. Pecquet, Jeanelle M. Martinez, et al. · Journal of Applied Toxicology · 11
PDF
Vanillin
2014 · A. Jenkins, N.K. Erraguntla · Elsevier eBooks · 11
Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadiene
2022 · C.R. Kirman, C.M. North, et al. · Regulatory Toxicology and Pharmacology · 9
A reproductive and developmental toxicity screening study of 1,3-butadiene in Sprague-Dawley rats
2021 · M. Sue Marty, Neeraja Erraguntla, et al. · Regulatory Toxicology and Pharmacology · 9
Industry-wide review of potential worker exposure to 1,3-butadiene during chemical manufacturing and processing as a reactant
2023 · Julie Panko, Liz Mittal, et al. · Journal of Occupational and Environmental Hygiene · 3
PDF
Health- and vegetative-based effect screening values for ethylene
2015 · Neeraja K. Erraguntla, Roberta L. Grant · Chemico-Biological Interactions · 3
Corrigendum to “An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene” [Chem. Biol. Interact. 366 (2022) 1–10]
2023 · C. Valdez-Flores, N. Erraguntla, et al. · Chemico-Biological Interactions
Industry-wide review of potential worker exposure to 1,3-butadiene during chemical manufacturing and processing as a reactant
2023 · Panko, Julie, Mittal, Liz, et al. · Figshare
Works count: 21
Citation count: 274
H-index: 11
I10-index: 11
Year
Topic
Type